![Alison Long](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alison Long
Direktör/Styrelseledamot på
TAYSHA GENE THERAPIES, INC.
Förmögenhet: 866 082 $ per 2026-06-30
Profil
Dr. Alison Long is an Independent Director at Taysha Gene Therapies, Inc. and a Chief Medical Officer at Flightpath Biosciences, Inc. She is on the Board of Directors at Taysha Gene Therapies, Inc. Dr. Long was previously employed as a Chief Medical Officer by Anokion SA, a Chief Medical Officer by Kaleido Biosciences, Inc., a Chief Medical Officer by Freeline Therapeutics Holdings Ltd., and a Head-Clinical R&D by Spark Therapeutics, Inc. She received her undergraduate degree from the University of the Witwatersrand and a doctorate degree from George Mason University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-01 | 127 178 ( 0,05 % ) | 866 082 $ | 2026-06-30 |
Aktiva positioner av Alison Long
| Företag | Position | Start |
|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Direktör/Styrelseledamot | 2023-11-01 |
Flightpath Biosciences, Inc.
 Flightpath Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Teknisk/Vetenskaplig/F&U Direktör | 2023-01-01 |
Tidigare kända positioner av Alison Long
| Företag | Position | Slut |
|---|---|---|
Anokion SA
 Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Teknisk/Vetenskaplig/F&U Direktör | 2023-01-01 |
| KALEIDO BIOSCIENCES, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2022-04-01 |
| FREELINE THERAPEUTICS HOLDINGS PLC | Teknisk/Vetenskaplig/F&U Direktör | 2021-11-01 |
| SPARK THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2020-06-01 |
Alison Longs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
47
Första gradens relationer
8
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
George Mason University
 George Mason University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Anokion SA
Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Health Technology |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Flightpath Biosciences, Inc.
Flightpath Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Health Technology |
Taysha Gene Therapies, Inc.
 Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system | Health Technology |
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Develops and manufactures next-generation gene therapies | Health Technology |
